Navigation Links
Generex Announces Results of Annual Stockholders' Meeting
Date:6/10/2011

WORCESTER, Mass. and TORONTO, June 10, 2011 /PRNewswire/ -- Generex Biotechnology Corporation (OTCBB: GNBT) (www.generex.com) today announced the results of the Company's annual meeting of stockholders held on June 8, 2011.

(Logo:  http://photos.prnewswire.com/prnh/20110106/NY25057LOGO-b)

At the annual meeting of stockholders, the following directors were elected to serve on the Board of Directors until the next annual meeting of stockholders:  John Barratt, Brian McGee, Nola Masterson, Mark Fletcher, Dr. James Anderson, and Dr. Eric Von Hofe, Ph.D.  Stockholders also ratified the appointment of MSCM LLP as the Company's independent registered public accounting firm for the year ending July 31, 2011.

In addition, the stockholders supported the Company's non-binding resolutions on the Company's executive compensation policies and practices and the Board of Director's recommendation to hold an advisory vote on executive compensation every two years.

The proposal to amend the Company's Restated Certificate of Incorporation to effect a reverse stock split was approved by the stockholders.  As stated in the proposal, the reverse stock split will only be effected if the Company's application for listing on a U.S. national stock exchange is approved contingent only upon the Company meeting the minimum share price requirement of such exchange.  The Company has not yet made any application to an exchange on those terms.  If the requisite conditions are met, the reverse stock split may be effected at any time prior to December 7, 2012.

"More than 75% of the Company's stock was voted at this meeting," commented Mark Fletcher, the Company's President & Chief Executive Officer.  "For a company with more than 37,000 stockholders, none of whom hold in excess of 5% of the outstanding stock
'/>"/>

SOURCE Generex Biotechnology Corporation
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. Generex Announces Publication on Application of Antigen Express Technology for Early Detection of Type 1 Diabetes
2. Generex Oral-lyn™ Data to be Presented at Two International Scientific Symposia
3. Generex Announces Publication of Comparative Peptide Vaccine Studies in Peer Review Journal Demonstrating Superiority of AE37 and Presentation at the American Association for Cancer Research
4. Generex Announces $3.0 Million Capital Investment
5. Generex Provides Additional Details for October 21st Live Video Webcast
6. Generex Common Stock to be Quoted on the OTCQB Under the Symbol GNBT Beginning Thursday, October 21, 2010
7. Generex Provides Additional Reverse Stock Split Information for the Consideration of Stockholders
8. Generex Scientific Advisor Weighs in on Reverse Stock Split Proposal
9. Generex Plans Rights Offering to Stockholders Following Reverse Stock Split
10. Generex Biotechnology Appoints Mark Fletcher as Interim President and CEO, and John P. Barratt as Chairman of the Board
11. Generex Announces That Adjournment will be Sole Matter Considered at Special Meeting of Stockholders on September 17, 2010
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... OXFORD, England , May 22, 2013 ... inhaled, novel drug-only formulation of glycopyrronium bromide designed using ... speciality pharmaceutical company developing a portfolio of inhaled ... 2 clinical study with PSX1002 that will assess its ... range of doses in patients with moderate to severe ...
(Date:5/21/2013)... Through science fairs, workshops, kits for building ... 25 organizations will continue their work to increase awareness ... in daily life with the aid of SPIE ... 10 countries, are the first of two groups of ... the international society for optics and photonics , in ...
(Date:5/21/2013)... 2013 Savoury Systems International (SSI), a ... Braddy to Southeastern USA Sales Broker. Braddy’s new role ... in the Southeast. , In 2004 Braddy ... supplier to food processors and industrial manufacturers. Braddy ... food industry and has over 25 years of sales ...
(Date:5/21/2013)... 2013 As the R&D sector ... within the industry to deliver better products, faster. ... pharma companies often means turning big ideas into ... in collaboration with Sensidose AB and Recipharm, is ... products to market sooner. The partnership resulted in ...
Breaking Biology Technology:Prosonix Initiates Phase 2 Clinical Study with PSX1002 in Patients with Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) 2Prosonix Initiates Phase 2 Clinical Study with PSX1002 in Patients with Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) 3Prosonix Initiates Phase 2 Clinical Study with PSX1002 in Patients with Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) 4Learning About Light: Education Outreach Projects Funded in 10 Countries Through First Round of SPIE Grants 2Learning About Light: Education Outreach Projects Funded in 10 Countries Through First Round of SPIE Grants 3The Development of an Innovative Microtablet Dosage Form, a Success Story: Live Webinar Hosted by Xtalks 2
... ... been selected by Prometheus as the sample collection kit for MyCeliacID™ a saliva-based genetic ... service as it solves sample collection challenges inherent with traditional collection methods which are ... ...
... CANTON, Mass., Aug. 18 Metabasis, a San Diego-based ... R&D equipment that is no longer essential to their ongoing ... and listed the premium lab and analytical equipment on the ... , , Metabasis is a biotech firm, ...
... , , ATLANTA, Aug. 18 ... medical device and cardiovascular tissue processing company, today announced the first ... FDA clearance. The surgeries were performed on pediatric patients at ... MI by Richard G. Ohye, M.D., associate professor of surgery, ...
Cached Biology Technology:DNA Genotek Sample Collection Kit Selected by Prometheus for MyCeliacID™ Genetic Test 2DNA Genotek Sample Collection Kit Selected by Prometheus for MyCeliacID™ Genetic Test 3Massive Inventory of Premium Lab & Analytical Equipment Now Available 2CryoLife Announces Implants of First FDA-Cleared SynerGraft(R) Processed Human Cardiac Patch Material 2CryoLife Announces Implants of First FDA-Cleared SynerGraft(R) Processed Human Cardiac Patch Material 3CryoLife Announces Implants of First FDA-Cleared SynerGraft(R) Processed Human Cardiac Patch Material 4
(Date:5/22/2013)... important new details on how climate change will affect ... in the Journal of Animal Ecology . This ... and informing policymakers of how species are likely to ... is a growing recognition among biologists that climate change ... that this is going to have very important consequences ...
(Date:5/22/2013)... May 22, 2013 Early screening for prostate cancer ... testing is for women, thanks to UC Irvine research ... Chemical Society . , After more than a decade ... to clearly identify clinically usable markers for prostate cancer ... far sooner, with greater accuracy and at dramatically lower ...
(Date:5/22/2013)... pollinating insects and wild plants have slowed in recent ... by the University of Leeds and the Naturalis Biodiversity ... reductions in the diversity of species in Britain, Belgium ... But the picture brightened markedly after 1990, with a ... hoverflies and wild plants. , Professor Bill ...
Breaking Biology News(10 mins):UCLA life scientists present new insights on climate change and species interactions 2UCLA life scientists present new insights on climate change and species interactions 3UCLA life scientists present new insights on climate change and species interactions 4UCLA life scientists present new insights on climate change and species interactions 5UCI chemists devise inexpensive, accurate way to detect prostate cancer 2UCI chemists devise inexpensive, accurate way to detect prostate cancer 3Encouraging signs for bee biodiversity 2Encouraging signs for bee biodiversity 3
... LANSING, Mich. An engineering researcher and a global ... bringing a low-cost, hand-held device to nations with limited ... Syed Hashsham, a professor of civil and environmental ... is operated using an iPod Touch or Android-based tablet ...
... that the salmon are biting less, there are less of ... researcher at the University of Oviedo (Spain). The study, ... shows a "very marked" decline in Atlantic salmon ( Salmo ... (Asturias, northern Spain), especially during the last decade, almost simultaneously ...
... Washington, DC (August 26, 2011) African Americans are four ... new study has found that a condition that occurs when ... contributes to this increased risk. The study, conducted ... appears in an upcoming issue of the Journal of ...
Cached Biology News:Hand-held unit to detect cancer in poorer countries 2The same number of fishermen, but less salmon in Spanish rivers 2
Ready-to-use solution....
ready-to-use solution...
Immunogen: Synthetic peptide (aa sequence is considered to be commercially sensitive) Storage: -20 C, Avoid Freeze/Thaw Cycles...
... Clone/PAD: ZMD.420. Immunogen: ... Specificity: Specific for the ... Reactivity: Human (positive control: ... Based on sequence homology reactivity ...
Biology Products: